Mirae Asset Healthcare Fund Direct Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 43.928 ↑ 0.45%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Mirae Asset Healthcare Fund Direct Growth 0.03% 0.45% 0.63% -0.75% -0.35% 1.66% 23.26% 19.5% 22.75%-

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.89% 0.01% (Arbitrage: 0.00%) 0.00% 0.00% 0.10%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology11.57%
Divi's Laboratories Ltd.Pharmaceuticals & Biotechnology7.76%
Glenmark Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology6.97%
Apollo Hospitals Enterprise Ltd.Healthcare Services6.23%
Cipla Ltd.Pharmaceuticals & Biotechnology6.03%
Lupin Ltd.Pharmaceuticals & Biotechnology5.05%
Aurobindo Pharma Ltd.Pharmaceuticals & Biotechnology4.33%
Dr. Reddy's Laboratories Ltd.Pharmaceuticals & Biotechnology4.19%
Fortis Healthcare Ltd.Healthcare Services4.19%
Krishna Institute of Medical Sciences Ltd.Healthcare Services3.74%
IPCA Laboratories Ltd.Pharmaceuticals & Biotechnology3.49%
Aster DM Healthcare Ltd.Healthcare Services3.40%
Cohance Lifesciences Ltd.Pharmaceuticals & Biotechnology3.30%
Eris Lifesciences Ltd.Pharmaceuticals & Biotechnology3.01%
Torrent Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology2.81%
Alkem Laboratories Ltd.Pharmaceuticals & Biotechnology2.80%
JB Chemicals & Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology2.78%
Onesource Specialty Pharma Ltd.Pharmaceuticals & Biotechnology2.74%
Sai Life Sciences Ltd.Pharmaceuticals & Biotechnology2.45%
Laurus Labs Ltd.Pharmaceuticals & Biotechnology2.29%
Wockhardt Ltd.Pharmaceuticals & Biotechnology1.87%
Gland Pharma Ltd.Pharmaceuticals & Biotechnology1.70%
Mankind Pharma Ltd.Pharmaceuticals & Biotechnology1.62%
Anthem Biosciences Ltd.Pharmaceuticals & Biotechnology1.45%
Biocon Ltd.Pharmaceuticals & Biotechnology0.92%
Deepak Nitrite Ltd.Chemicals & Petrochemicals0.83%
Sagility Ltd.IT - Services0.81%
Neogen Chemicals Ltd.Chemicals & Petrochemicals0.56%
Syngene International Ltd.Healthcare Services0.51%
Laxmi Dental Ltd.Healthcare Equipment & Supplies0.48%

Debt

NameRatingWeight %
Mirae Asset Liquid Fund-Direct Plan-Growth0.01%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

Mirae Asset Healthcare Fund Direct Growth - 30 days NAV history

DateNAV
20 October, 202543.928
17 October, 202543.730
16 October, 202543.641
15 October, 202543.445
14 October, 202543.331
13 October, 202543.651
10 October, 202543.600
9 October, 202543.192
8 October, 202542.882
7 October, 202543.037
6 October, 202542.948
3 October, 202542.582
1 October, 202542.529
30 September, 202542.189
29 September, 202542.207
26 September, 202542.130
25 September, 202542.972
24 September, 202543.222
23 September, 202543.508
22 September, 202543.659
19 September, 202544.260
18 September, 202544.010
17 September, 202543.660
16 September, 202543.771
15 September, 202543.670
12 September, 202543.877
11 September, 202543.789
10 September, 202543.613
9 September, 202543.447
8 September, 202543.104

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
    The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 43.928 as on 20 October, 2025.
  • What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
    The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are 0.03% as on 20 October, 2025.
  • What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
    The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 1.66% as on 20 October, 2025.
  • What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 23.26% as on 20 October, 2025.
  • What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 19.5% as on 20 October, 2025.